South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns 
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure 
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals 
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal 
South Africa Eyes ECB Repo Lines as Inflation Eases and Rate Cuts Loom 
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Gold and Silver Prices Slide as Dollar Strength and Easing Tensions Weigh on Metals 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
The Kroger Company will settle its opioids lawsuit in West Virginia by paying $68 million. In this case, the retailer was accused of contributing to the oversupply of the said drugs that are legally available with a prescription.
The state of West Virginia also alleged that Kroger failed to control the sale of opioids which is a type of drug that includes heroin which is illegal. Synthetic opioids like fentanyl and pain relievers are being sold to patients with prescriptions so they can be purchased in leading drug stores.
Patrick Morrisey, the West Virginia Attorney General, confirmed on Thursday, May 3, that Kroger has settled the lawsuit. The Cincinnati, Ohio-headquartered retail chain is the last defendant in the case, which also involves other major drug stores in the United States, including Rite Aid, Walgreens, CVS, and Walmart.
“Although the hundreds of millions of dollars we secured from these companies will not bring back the lives lost from the opioid menace, our hope is that the money would provide significant help to those affected the most by this crisis in the state,” the attorney general said in a statement.
On the other hand, Kroger’s spokesman also commented that while the company “continues to believe that the allegations made against Kroger in this and other opioid lawsuits are without merit, we have decided that a settlement is the best path forward to resolve this litigation.”
At any rate, CNN Business reported that despite the hefty payment to resolve the opioid suit, the financial impact on Kroger will remain minimal. This is because it reported $4.1 billion in earnings in 2022.
Walgreens also settled with the state of West Virginia in January this year and paid $83 million, while CVS and Walmart resolved the suit with settlements of $82.5 million and $65 million, respectively, in late 2022. In the case of Rite Aid, it paid up to $30 million in August of last year.
Photo by: Mike Kalasnik/Flickr (CC BY-SA 2.0)
